Image 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
Background<p>Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with poor prognosis. Efferocytosis, an essential process for clearing apoptotic cells, is involved in shaping immunosuppressive microenvironment, facilitating tumor immune evasion. This study aims to evaluate the...
Guardat en:
| Autor principal: | Xiangjun Wang (2522917) (author) |
|---|---|
| Altres autors: | Wei Wang (17594) (author), Chuanxin Yang (18266948) (author), Puxiongzhi Wang (3877201) (author), Yangming Liu (12254459) (author), Liqin Yu (1461880) (author), Sijie Zhang (7429373) (author), Xiaoyu Yan (500545) (author), Jian Wang (5901) (author) |
| Publicat: |
2025
|
| Matèries: | |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Ítems similars
-
Image 9_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
per: Xiangjun Wang (2522917)
Publicat: (2025) -
Image 8_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
per: Xiangjun Wang (2522917)
Publicat: (2025) -
Image 6_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
per: Xiangjun Wang (2522917)
Publicat: (2025) -
Image 7_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
per: Xiangjun Wang (2522917)
Publicat: (2025) -
Image 4_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
per: Xiangjun Wang (2522917)
Publicat: (2025)